ACAS News Alert American Capital (ACAS) 13.97 12/17/2014 02:

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
American Capital (ACAS) 13.97 $ACAS

American Capital Agency Corp. Declares Monthly Common Stock Dividend for December 2014 and Announces Estimated Net Asset Value as of November 30, 2014
PR Newswire - Mon Dec 15, 3:01PM CST
American Capital Agency Corp. (Nasdaq: AGNC) ("AGNC" or the "Company" announced today that its Board of Directors has declared a cash dividend of $0.22 per share of common stock for December 2014. The dividend is payable on January 9, 2015 to common shareholders of record as of December 31, 2014, with an ex-dividend date of December 29, 2014.
ACAS: 13.97 (-0.14), MTGE: 19.06 (-0.15), AGNC: 21.77 (-0.09), ACSF: 12.26 (+0.01)

American Capital, Ltd. - Significant Upside From Upcoming Restructuring Plan
Mark Zusy - Seeking Alpha - Mon Dec 08, 2:30PM CST
American Capital, Ltd. (NASDAQ: ACAS ) closed at $15.10 on Friday (12/5), up a meager 3.0% since the Company's broad-brush announcement on November 5th of its restructuring plan to enhance shareholder value. Despite news of the planned...
ACAS: 13.97 (-0.14)

American Capital makes $31.5M M&A investment
Seeking Alpha - at Seeking Alpha - Wed Dec 03, 2:28PM CST

ACAS: 13.97 (-0.14)

American Capital Invests $31.5 Million to Support the Acquisition of Teasdale Foods, Inc.
PR Newswire - Wed Dec 03, 1:00PM CST
American Capital, Ltd. (Nasdaq: ACAS) ("American Capital" announced today that it has invested $31.5 million to support the acquisition of Teasdale Foods, Inc. ("Teasdale" by affiliates of Snow Phipps Group, LLC. Teasdale is a leading provider of private label and branded bean and hominy products to the retail, food service and wholesale channels. American Capital's investment takes the form of a second lien term loan.
ACAS: 13.97 (-0.14), MTGE: 19.06 (-0.15), AGNC: 21.77 (-0.09), ACSF: 12.26 (+0.01)

Ares Management fund buys U.K.-based paint retailer
Seeking Alpha - at Seeking Alpha - Mon Dec 01, 8:49AM CST

ACAS: 13.97 (-0.14), ARES: 16.69 (+0.04)

Ares Management Private Equity Fund to Acquire Farrow & Ball
Business Wire - Mon Dec 01, 7:01AM CST
Ares Management, L.P. (NYSE:ARES) announced today that a fund managed by its Private Equity Group has acquired Farrow & Ball, a global leader in high quality paint and wallpaper, from European Capital Limited, a wholly-owned investment affiliate of American Capital, Ltd (NASDAQ:ACAS). Farrow & Ball's senior management will retain a minority stake.
ACAS: 13.97 (-0.14), ARES: 16.69 (+0.04)

European Capital Completes Sale of Farrow & Ball for GBP 275 Million
PR Newswire - Mon Dec 01, 7:00AM CST
European Capital Limited ("European Capital" announced today that it has completed the sale of its portfolio company Farrow & Ball to Ares Management for £275 million (EUR 347 million or $433 million). European Capital received £236 million in equity proceeds (having previously received full repayment on the senior and mezzanine debt) and realised a gain of £138 million from the transaction, subject to closing adjustments. European Capital's compounded annual rate of return earned on its debt and equity securities over the life of its investment was 22%, including interest, dividends, realised gains and fees. European Capital received 5.4 times its equity investment and realised a compounded annual rate of return of 23% over the life of its equity investment, including dividends, realised gains and fees.
ACAS: 13.97 (-0.14), MTGE: 19.06 (-0.15), AGNC: 21.77 (-0.09), ACSF: 12.26 (+0.01)

American Capital closes $411M managed CLO
Seeking Alpha - at Seeking Alpha - Tue Nov 25, 3:33PM CST

ACAS: 13.97 (-0.14)

American Capital Closes $411 Million Managed CLO
PR Newswire - Tue Nov 25, 3:01PM CST
American Capital, Ltd. (Nasdaq: ACAS) ("American Capital" announced today that an affiliate, ACAS CLO 2014-2, Ltd. ("ACAS CLO 2014-2" , has closed on the sale of $411 million of collateralized loan obligation ("CLO" bonds. The transaction was arranged by Wells Fargo Securities, LLC. ACAS CLO 2014-2 is externally managed by American Capital CLO Management, LLC, which is a subsidiary of American Capital Asset Management, LLC, a wholly-owned portfolio company of American Capital, for an annual management fee of 50 basis points on total assets.
ACAS: 13.97 (-0.14), MTGE: 19.06 (-0.15), AGNC: 21.77 (-0.09), ACSF: 12.26 (+0.01)

The Paradox Of Cheap Oil
Philip Mause - at Seeking Alpha - Mon Nov 24, 11:35PM CST

NLY: 11.07 (-0.12), NOG: 5.28 (-0.04), ACAS: 13.97 (-0.14), LXP: 10.66 (-0.04), ARCC: 14.66 (-0.23), HPT: 30.53 (+0.10), XOM: 86.41 (-0.49), COP: 63.22 (+1.53), SLB: 80.19 (+0.29)

American Capital Earnings Hindsight: Up 1.5% in Last 19 Days (ACAS)
Comtex SmarTrend(R) - Mon Nov 24, 9:31AM CST
Two weeks ago on November 5th, 2014 American Capital (NASDAQ:ACAS) reported earnings and analysts, on average, expected earnings of $0.17 on sales of $110.5 million. The company actually reported EPS of $0.24 on sales of $129.0 million, beating EPS estimates by $0.07 and beating revenue estimates by $18.5 million. Since the company's report, shares of American Capital have risen from $14.66 to $14.88, representing a gain of 1.5% in the past 19 days.
ACAS: 13.97 (-0.14)

American Capital Investment Outlook - Quarterly Update
Alan Stacy - at Seeking Alpha - Thu Nov 20, 1:07PM CST

ACAS: 13.97 (-0.14)

Asset Management and Custody Banks Equities Under Review - Bank of NYSE Mellon, Prospect Capital, KKR and Co., American Capital, and State Street
PR Newswire - Tue Nov 18, 7:50AM CST
Investor-Edge has initiated coverage on the following equities: The Bank of New York Mellon Corporation (NYSE: BK), Prospect Capital Corporation (NASDAQ: PSEC), KKR and Company L.P. (NYSE: KKR), American Capital Ltd (NASDAQ: ACAS), and State Street Corporation (NYSE: STT). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Monday, November 17, 2014, the NASDAQ Composite ended at 4,671.00, down 0.37%, the Dow Jones Industrial Average advanced 0.07%, to finish the day at 17,647.75, and the S&P 500 closed at 2,041.32, up 0.07%. The losses were broad based as six out of ten sectors ended the session in negative. The S&P 500 Financials Sector Index ended the day at 323.77, up 0.02%, with the index also advancing 7.70% in the last one month. Register for your complimentary reports on these five stocks at:
ACAS: 13.97 (-0.14), STT: 74.89 (-0.53), KKR: 21.82 (-0.27), BK: 39.62 (-0.10), PSEC: 8.32 (+0.15)

CORRECTION - American Capital Agency Corp. November 2014 Ex-Dividend Date
PR Newswire - Mon Nov 17, 6:04PM CST
As a correction to the press release issued earlier today by American Capital Agency Corp. (Nasdaq: AGNC) ("AGNC" or the "Company" regarding the declaration of the Company's November 2014 common stock dividend, due to a Nasdaq holiday, the ex-dividend date will be November 25, 2014 instead of November 26, 2014. The dividend will continue to be paid on December 5, 2014 to common shareholders of record as of November 28, 2014.
ACAS: 13.97 (-0.14), MTGE: 19.06 (-0.15), AGNC: 21.77 (-0.09), ACSF: 12.26 (+0.01)

American Capital Earnings Review: 12 Days after Announcement Shares Up 3.1% (ACAS)
Comtex SmarTrend(R) - Mon Nov 17, 3:31PM CST
12 days ago, on November 5th, 2014, American Capital (NASDAQ:ACAS) reported its earnings. Analysts, on average, expected earnings of $0.17 per share on sales of $110.5 million. American Capital actually reported earnings of $0.24 per share on sales of $129.0 million, beating EPS estimates by $0.07 and beating revenue estimates by $18.5 million. Since the company's report, shares of American Capital have risen from $14.66 to $15.11, representing a gain of 3.1% in the past 12 days.
ACAS: 13.97 (-0.14)

American Capital Agency Corp. Declares Monthly Common Stock Dividend for November 2014 and Announces Estimated Net Asset Value as of October 31, 2014
PR Newswire - Mon Nov 17, 3:01PM CST
American Capital Agency Corp. (Nasdaq: AGNC) ("AGNC" or the "Company" announced today that its Board of Directors has declared a cash dividend of $0.22 per share of common stock for November 2014. The dividend is payable on December 5, 2014 to common shareholders of record as of November 28, 2014, with an ex-dividend date of November 26, 2014.
ACAS: 13.97 (-0.14), MTGE: 19.06 (-0.15), AGNC: 21.77 (-0.09), ACSF: 12.26 (+0.01)

Total Returns For BDC Portfolios: November 2014
BDC Buzz - at Seeking Alpha - Mon Nov 17, 5:04AM CST

NMFC: 14.14 (-0.14), ACAS: 13.97 (-0.14), MAIN: 28.08 (-1.51), SLRC: 17.23 (-0.39), BKCC: 8.00 (-0.16), TICC: 7.46 (-0.17), SUNS: 14.92 (-0.08), GBDC: 17.02 (-0.30), HRZN: 13.46 (+0.01), PFLT: 12.99 (-0.26), GLAD: 8.39 (-0.20), TCPC: 15.48 (-0.20), TCRD: 11.31 (-0.31), ARCC: 14.66 (-0.23), BDCL: 19.72 (-0.48), FSC: 7.82 (-0.09), MCGC: 3.56 (-0.02), AINV: 7.26 (-0.10), TSLX: 16.51 (-0.58), MCC: 8.84 (-0.06), FDUS: 13.91 (+0.20), PSEC: 8.32 (+0.15), FSIC: 10.04 (-0.17)

Insider Trading Alert - WBS, LUV And ACAS Traded By Insiders
at The Street - Fri Nov 14, 10:31AM CST
Stocks with insider trader activity include WBS, LUV and ACAS
ACAS: 13.97 (-0.14), WBS: 30.99 (+0.27), LUV: 39.58 (-2.00)

A So-So Q3 For 11.7% Dividend American Capital Agency Still Leaves It Looking Good
David White - at Seeking Alpha - Tue Nov 11, 12:51AM CST

ACAS: 13.97 (-0.14), AGNC: 21.77 (-0.09)

Update: American Capital Q3 '14 Earnings And Split Into Three Companies
Stone Fox Capital - at Seeking Alpha - Mon Nov 10, 2:27AM CST

ACAS: 13.97 (-0.14)




Scroll down for more posts ▼

Top 10 Most Recent News Articles

Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 180

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Cottage Grove Tests Holiday Demand Across Lake Norman

Updated Category News Views 154

Flour and foot traffic make a pretty honest little scoreboard. Cottage Grove Bakery is putting itself in front of Lake Norman shoppers twice on Saturday, November 21, while also taking Thanksgiving orders and laying groundwork for 2027 workplace and school visits. This is not a public-company earnings story, and nobody should pretend a tray of scones is a quarterly...

Continue Reading
Fractional CIOs Bring Order to Growing Technology Chaos

Updated Category News Views 71

A company can outgrow its technology habits long before anyone notices the smoke. One day the owner is approving another software subscription, the office manager is chasing an internet provider, and the tech person is putting out password fires. None of that looks dramatic in isolation. Together, it is a business operating without a map. That is the useful point in the...

Continue Reading
Fluence Investors Face a November 27 Litigation Clock

Updated Category News Views 157

Six calendar squares are all that separate eligible Fluence investors from the November 27, 2026 lead-plaintiff deadline. That is not much time to locate trade confirmations, calculate losses, and decide whether taking a larger role in a securities case makes sense. The lawsuit is not a verdict, and anybody pretending otherwise is selling smoke. But the underlying...

Continue Reading
Epic Blue Puts $50,000 of Marketing Work to Use Locally

Updated Category News Views 136

A $50,000 pile of donated know-how can look soft on a spreadsheet, until you remember how often a small nonprofit or early-stage outfit gets ignored because it cannot afford someone to sharpen its message. Epic Blue Marketing, a women-owned firm based in Jackson, Michigan, says it provided that amount in donated and reduced-rate marketing, communications and public...

Continue Reading
3TREES Tests a Bigger Asia-Pacific Growth Blueprint

Updated Category News Views 154

A bucket of paint rarely sounds strategic until it sits inside a regional supply chain. That is the useful part of 3TREES chairman and president Hong Jie's message from the Asia-Pacific Economic Cooperation CEO Summit in Shenzhen on November 17-18, 2026: coatings are not merely a commodity if the supplier can bring materials, energy savings, technical know-how and...

Continue Reading
UAE Trust Model Faces Its Hardest Test During Crisis

Updated Category News Views 27

A country’s reputation is usually invisible right up until the machinery rattles. Then people, investors, trading partners and residents stop listening to polished slogans and start watching whether airports function, services hold up, information arrives, and business can keep moving. That was the useful core of Saeed Al Eter’s remarks at Ajman Media Forum 2026: soft...

Continue Reading
Kyverna Probe Reopens IPO Disclosure Questions for Investors

Updated Category News Views 93

Clinical-trial caveats have a nasty habit of becoming shareholder headaches years later. Kyverna Therapeutics is back in that uncomfortable zone after Kahn Swick & Foti said it has opened an investigation into whether the company’s officers and directors breached fiduciary duties or otherwise violated state or federal law. For holders of KYTX, this is not a verdict and...

Continue Reading
Sitting, Lymph Flow, and a Supplement Maker's Pitch

Updated Category News Views 129

By late afternoon, a chair can feel like it has quietly won the argument against your legs. PureHealth Research is leaning into that familiar heavy, puffy-legged feeling with a reminder about lymphatic flow—and, naturally, an eight-ingredient supplement positioned alongside it. The broad message is sensible. The sales layer needs the usual healthy squint. Movement Does...

Continue Reading
Maryland Handgun Ban Suit Puts Ruger in Legal Crossfire

Updated Category News Views 150

A January Deadline With Real Commercial Teeth Maryland has turned a trigger-design dispute into a fresh legal and retail headache, and the clock is not polite about it. The National Shooting Sports Foundation filed suit against the state over S.B. 334, which is scheduled to take effect Jan. 1, 2027. The law bars sales of certain pistols with cruciform trigger bars,...

Continue Reading

Top 5 Most Recently Viewed Articles

Coca-Cola's Emerging Markets Strategy Fuels Long-Term Growth

Updated Category News Views 929

Coca-Cola's Position in Emerging Markets Coca-Cola Co (NYSE: KO) stands as a beacon of growth, with a visionary strategy that highlights both immediate and long-term opportunities. The company has successfully positioned itself in vital markets, particularly in North America and Latin America, which have proven central to its success. According to recent insights from...

Continue Reading
Voda IQ Appoints Armando Piccinini to Drive European Sales

Updated Category News Views 121

Voda IQ dropped some big news back in 2024 when they appointed Armando Piccinini as their European Sales Director. This guy’s got over twenty years under his belt in aquatic conservation, which they clearly hope will ramp up their sales strategy across Europe. But you gotta wonder—are the numbers behind this move really there? Can Experience Translate to Sales Growth?...

Continue Reading
Magnera Corporation to Shine at Upcoming Finance Conference

Updated Category News Views 163

Magnera Corporation's Conference Participation Announcement Magnera Corporation (NYSE: MAGN) has made an exciting announcement regarding its upcoming participation in a significant financial event. The company is set to be a part of the 2025 Bank of America Leveraged Finance Conference, aimed at fostering connections with top institutional investors. The event will take...

Continue Reading
Bullish Momentum Unveiled: Insights on Merck & Co Stocks

Updated Category News Views 180

Exciting Developments in Merck & Co Options Activity Notable investors are expressing strong optimism about Merck & Co. A recent analysis of options trading strategies reveals a wave of activity among traders aiming to capitalize on this potential. Options Trading Overview When reviewing the options history for Merck & Co (NYSE: MRK), we found a total of 33 trades that...

Continue Reading
Gilead Snags Arcellx: A High-Stakes Cancer Gamble Unfolds

Updated Category News Views 195

The Big Play for Cancer Innovation Gilead Sciences Inc. (NASDAQ:GILD) pulled the trigger on a pretty huge acquisition deal, landing Arcellx Inc. (NASDAQ:ACLX) this past Monday for a staggering $115 per share, which gets better with a potential extra $5 per share on a contingent value right. That rings in a hefty total of $7.8 billion—no pocket change, folks. What’s...

Continue Reading